2016-03-08T00:00:00.000-05:00
Cempra,-0.495959
critical medical needs,-0.5923
Nature webcast,0.31048
antibiotic resistance,0.240394
Inc.,-0.678316
gastric motility disorders,-0.889503
new treatments,-0.410987
roundtable discussion,0.316828
Interested parties,0.503897
chronic inflammatory diseases,-0.840354
GLOBE NEWSWIRE,0.238546
advanced clinical development,0.344395
bacterial infectious diseases,-0.5923
clinical-stage pharmaceutical company,-0.5923
non-antibiotic uses,-0.840354
antibiotics,-0.5923
chronic oral treatment,-0.672885
Q&A section,0.316828
skin structure,-0.449758
acute bacterial skin,-0.449758
innovative antibiotic companies,0.300847
novel macrolides,-0.840354
lead product candidates,0.344395
drug-resistant bacterial infections,-0.410987
refractory infections,-0.672885
endocrine diseases,-0.889503
exploratory study,-0.672885
